MORE NATIONAL NEWS
United States News
News from the region's first prime-time newscast. You'll find it First On Fox!
FDA lowers starting dose of sleeping aid Lunesta due to risks of next-day driving impairment
Reported by: Associated Press
Reported: Thursday, May 15, 2014 1:26 PM EDT
Federal health officials say the maker of Lunesta must lower the starting dose of its sleeping aid drug due to risks of morning drowsiness, which can interfere with driving ability and lead to injury.
Lunesta manufacturer Sunovion Pharmaceuticals will lower the starting dose of the tablet to 1 milligram from 2 milligrams. Patients can increase their dose, but should remember that higher doses are more likely to cause impairment the next day, according to the FDA.
Drowsiness is a side effect for all anti-insomnia drugs.